Table 7.
Antitumor activities of components from Agrimonia pilosa Ledeb.
A. pilosa extract | Experimental model | Test dose range | Contrast | Route of administration | Pharmacological action | Mechanism of action | References |
---|---|---|---|---|---|---|---|
Quercetin | AGS cells | 6.25, 12.5, 25, 50, and 100 μM | SN-38 (6.25, 12.5, 25, 50, and 100 μM) | NS | Sensitize AGS to SN-38 | NS | [55] |
Quercetin | AGS inoculate BALB/c nude mice | 20 mg/kg, three times a week + IRI; 10 mg/kg, once a week | IRI; 10 mg/kg, once a week 20 mg/kg, three times a week | i.p. | Sensitize AGS to SN-38 | NS | [55] |
Agrimonolide | AGS cells | 5, 10, 20, and 40 μM | Negative control | NS | Apoptosis-inducing | Bcl-2/Bax↑, p-p38↑ and caspase-3 protease activation | [56] |
Beta-carotene | AGS cells | 0, 20, 50, and 100 μmol/L | Negative control | NS | Apoptosis-inducing and DNA fragmentation | Bcl-2/Bax↑,p-53↑ | [1] |
Agrimol B | PC-3 cells | 0, 6.25, 12.5, and 25 μmol/L | Negative control | NS | Arrest cancer cells at G0 phase | p27↑, SKP2↓,cMYC↓ | [57] |
Agrimol B | A549 cells | 0, 6.25, 12.5, and 25 μmol/L | Negative control | NS | Arrest cancer cells at G0 phase | SKP2↓, cMYC↓, SPT16↓ and SSRP1↓, p27↑ | [57] |
Ellagic acid | PC-3 cells | 0, 6.25, 12.5, and 25 μmol/L | Negative control | NS | Arrest cancer cells at G0 phase | c-MYC↓, SKP2↓, SPT16↓, SSRP1↓, p27↑ | [57] |
Ellagic acid | A549 cells | 0, 6.25, 12.5, and 25 μmol/L | Negative control | NS | Arrest cancer cells at G0 phase | c-MYC↓, SKP2↓, SPT16↓, SSRP1↓, CRM1↓, p27↑ | [57] |
Agrimol B | PC-3 inoculated male BALB/c nude mice | 10 mg/kg | Negative control | p.o. | Tumor growth reducing | NS | [57] |
Apigenin | PC-3 cells | 20, 40 μM | Negative control | NS | Apoptosis inducing | HDACs↓, especially HDAC1↓ and HDAC3↓ | [58] |
Apigenin | PC-3 xenografts in athymic nude mice | 20 and 50 μg/mouse/day | Negative control | p.o. | Tumor growth reducing | HDACs↓ p21/waf1↑, Bax/bcl2↑ | [58] |
Quercetin | MCF-7 cells | 0–100 μg/ml, IC50 = 0.87 μg/mL | Negative control | NS | Cytotoxicity | May be related to the presence of 2,3-double bond in ring C, carbonyl group at C-4 and ortho-hydroxylation in ring B | [59] |
Agrimophol | K562 cells | 0.1, 1, 10 mg/ml | Vincristine (50 IU/ml) | NS | Apoptosis inducing | NS | [60] |
Agripinol A | HCT-116, MDA-MB-231 and PC-3 cells | (IC50 = 12.34 ± 0.93, 5.44 ± 0.35, 9.47 ± 0.70, 14.29 ± 1.24 μg/ml, respectively) | Fluorouracil | NS | Cytotoxicity | NS | [45] |
Agripinol B | HCT-116, MDA-MB-231 and PC-3 cells | (IC50 = 12.34 ± 0.93, 5.44 ± 0.35, 9.47 ± 0.70, 14.29 ± 1.24 μg/ml, respectively) | Fluorouracil | NS | Cytotoxicity | NS | [45] |
Agripinol C | HCT-116, MDA-MB-231 and PC-3 cells | (IC50 = 12.63 ± 1.40, 2.12 ± 0.16, 7.50 ± 0.86, 9.85 ± 1.08 μg/ml, respectively) | Fluorouracil | NS | Cytotoxicity | NS | [45] |
Agrimoniin | MM2 inoculated C3H/H e and BALB/ c mice | 1, 3, 10, 30 mg/kg | Negative control | i.p. | Prolonged the life span of mice bearing MM2 | Direct inhibit tumor cell activity and increased the number of peripheral white blood cells and the ratio of monocytes | [61] |
Quercetin and hyperoside in combination (1 : 1 ratio) | 786-O renal cancer cells | 3.8–60 μg/ml | Negative control | NS | Cancer cell proliferation inhibition | ZBTB10↑ Sp1, Sp3, and Sp4 mRNA↓ | [62] |